Prediction of Prostate Cancer Risk Among Men Undergoing Combined MRI-targeted and Systematic Biopsy Using Novel Pre-biopsy Nomograms That Incorporate MRI Findings
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Initial Prostate Biopsy: Development and Internal Validation of a Biopsy-specific Nomogram Based on the Prostate Cancer Antigen 3 AssayEuropean Urology, 2013
- Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2012
- Development of Improved Nomogram for Prediction of Outcome of Initial Prostate Biopsy Using Readily Available Clinical InformationUrology, 2011
- Role of MRI in Minimally Invasive Focal Ablative Therapy for Prostate CancerAmerican Journal of Roentgenology, 2011
- Validation of Pretreatment Nomograms for Predicting Indolent Prostate Cancer: Efficacy in Contemporary Urological PracticeJournal of Urology, 2008
- A Novel Nomogram to Predict the Probability of Prostate Cancer on Repeat BiopsyJournal of Urology, 2008
- Development and External Validation of an Extended Repeat Biopsy NomogramJournal of Urology, 2007
- Prostate Cancer Nomograms: An UpdateEuropean Urology, 2006
- Counseling Men With Prostate Cancer: A Nomogram for Predicting the Presence of Small, Moderately Differentiated, Confined TumorsJournal of Urology, 2003
- A Nomogram For Predicting a Positive Repeat Prostate Biopsy in Patients With a Previous Negative Biopsy SessionJournal of Urology, 2003